| Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453, 2016 | 1579 | 2016 |
| The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine A Garofalo, L Sholl, B Reardon, A Taylor-Weiner, A Amin-Mansour, ... Genome medicine 8, 1-10, 2016 | 186 | 2016 |
| Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 183 | 2021 |
| Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ... Cancer discovery 7 (9), 973-983, 2017 | 121 | 2017 |
| Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytoma RK Gopal, SE Calvo, AR Shih, FL Chaves, D McGuone, E Mick, KA Pierce, ... Proceedings of the National Academy of Sciences 115 (27), E6283-E6290, 2018 | 86 | 2018 |
| Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study AA Ghazani, NM Oliver, JP St Pierre, A Garofalo, IR Rainville, E Hiller, ... Genetics in Medicine 19 (7), 787-795, 2017 | 57 | 2017 |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ... Cancer Cell 41 (1), 210-225. e5, 2023 | 53 | 2023 |
| Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma S Alig, CW Macaulay, DM Kurtz, U Dührsen, A Hüttmann, C Schmitz, ... Journal of Clinical Oncology 39 (23), 2605-2616, 2021 | 44 | 2021 |
| Circulating DNA for molecular response prediction, characterization of resistance mechanisms and quantification of CAR T-cells during axicabtagene ciloleucel therapy B Sworder, DM Kurtz, C Macaulay, MJ Frank, S Alig, A Garofalo, B Sahaf, ... Blood 134, 550, 2019 | 18 | 2019 |
| S-phase-dependent p50/NF-кB1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability CD Crawley, S Kang, GM Bernal, JS Wahlstrom, DJ Voce, KE Cahill, ... Cell Cycle 14 (4), 566-576, 2015 | 17 | 2015 |
| p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability L Wu, CD Crawley, A Garofalo, JW Nichols, PA Campbell, GF Khramtsova, ... Nature communications 11 (1), 5007, 2020 | 10 | 2020 |
| Towards non-invasive classification of DLBCL genetic subtypes by Ctdna profiling MS Esfahani, S Alig, DM Kurtz, J Soo, MC Jin, C Macaulay, AFM Craig, ... Blood 134, 551, 2019 | 9 | 2019 |
| Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ... Nature 625 (7996), 778-787, 2024 | 6 | 2024 |
| Distinct molecular subtypes of classic Hodgkin lymphoma identified by comprehensive noninvasive profiling SK Alig, M Shahrokh Esfahani, MY Li, RM Adams, A Garofalo, MC Jin, ... Blood 140 (Supplement 1), 1295-1296, 2022 | 6 | 2022 |
| Inherited mutations in DNA repair genes in men with metastatic castration-resistant prostate cancer. P Nelson, J Mateo, H Beltran, N De Sarkar, O Elemento, MA Rubin, ... Journal of Clinical Oncology 34 (15_suppl), 5009-5009, 2016 | 5 | 2016 |
| Molecular monitoring of lymphomas JG Schroers-Martin, S Alig, A Garofalo, B Tessoulin, T Sugio, AA Alizadeh Annual Review of Pathology: Mechanisms of Disease 18, 149-180, 2023 | 4 | 2023 |
| DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA B Sworder, DM Kurtz, S Alig, MJ Frank, CW Macauley, A Garofalo, ... Hematological Oncology 39, 2021 | 4 | 2021 |
| Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer. DM Kurtz, JJ Chabon, B Sworder, L Co Ting Keh, J Soo, S Alig, A Schultz, ... Journal of Clinical Oncology 39 (15_suppl), 8518-8518, 2021 | 3 | 2021 |
| Profiling T-cell receptor diversity and dynamics during lymphoma immunotherapy using cell-free DNA (cfDNA) ND Shukla, AFM Craig, B Sworder, DM Kurtz, C Macaulay, A Garofalo, ... Blood 136, 49-50, 2020 | 3 | 2020 |
| Distinct Hodgkin lymphoma subtypes identified by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo 17th International Conference on Malignant Lymphoma, 2023 | 2 | 2023 |
